The Barkby Group PLC
("Barkby", the "Group" or the "Company")
Posting of Annual Report & Notice of AGM
The Barkby Group PLC (AIM:BARK), the diversified business group, will today post its Annual Report and Accounts for the period ended 2 July 2020 and a notice convening the Company's 2021 Annual General Meeting ("AGM"). These documents are available for viewing on the Company's website at www.barkbygroup.com.
Details of the AGM
The AGM will be held at 115b Innovation Drive, Milton, Abingdon, England, OX14 4RZ at 10.00 a.m. on 7 May 2021.
In line with UK Government restrictions relating to public gatherings, the AGM will be run as a closed meeting and shareholders will not be able to attend in person. Shareholders are asked instead to vote by proxy on the resolutions contained in the AGM Notice.
Enquiries:
| The Barkby Group PLC | |
| Charles Dickson, Executive Chairman Douglas Benzie, Chief Financial Officer | |
| | |
| finnCap Ltd (Nomad and Broker) | +44 (0) 20 7220 0500 |
| Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
| |
| | |
| Camarco (Financial PR) | +44 (0) 20 3757 4994 |
| Jennifer Renwick/Jake Thomas
| |
Notes to editors
The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive Ltd.
In addition to these businesses, Barkby Life Sciences has invested in Verso Biosense, a digital health company aiming to transform Women's Health with precision medicine, and its subsidiary Cambridge Sleep Sciences Ltd has launched, SleepHub™, a device which improves and facilitates natural sleep.
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
